[1]
Ogawa, S. et al. 2022. Hyponatremia timing, incidence, and associated risk factors in patients treated with cisplatin for lung cancer: a retrospective study. Journal of Population Therapeutics and Clinical Pharmacology. 29, 04 (Dec. 2022), 1–10. DOI:https://doi.org/10.47750/jptcp.2022.907.